Ars Pharmaceutica

Scope & Guideline

Fostering collaboration for transformative pharmaceutical insights.

Introduction

Delve into the academic richness of Ars Pharmaceutica with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageMulti-Language
ISSN0004-2927
PublisherUNIV GRANADA, EDITORIAL
Support Open AccessNo
Country-
TypeJournal
Convergefrom 1980 to 1981, from 1983 to 1984, from 1986 to 2001, from 2003 to 2017 (coverage discontinued in Scopus)
AbbreviationARS PHARM / Ars Pharm.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressANTIGUO COLEGIO MAXIMO, CAMPUS DE CARTUJA, GRANADA 18071, SPAIN

Aims and Scopes

Ars Pharmaceutica is dedicated to advancing the field of pharmaceutical sciences through rigorous research and analysis. The journal encompasses a diverse range of topics relevant to pharmacology, drug development, clinical pharmacy, and health care practices, reflecting its commitment to improving patient care and public health.
  1. Pharmacological Research and Drug Development:
    The journal prioritizes studies related to the discovery, development, and optimization of pharmaceutical compounds, including bioavailability, pharmacokinetics, and therapeutic efficacy.
  2. Clinical Pharmacy and Therapeutics:
    A significant focus on clinical applications of pharmacy, including medication management, adherence, and the role of pharmacists in patient care.
  3. Public Health and Drug Safety:
    Research addressing drug-related problems, medication safety, and public health implications, including the evaluation of drug use patterns and adverse effects.
  4. Analytical and Methodological Advances:
    Innovations in analytical techniques for drug quantification and characterization, alongside the development of new methodologies for pharmaceutical research.
  5. Ethnopharmacology and Natural Products:
    Investigation of traditional medicine and natural compounds, assessing their pharmacological properties and potential therapeutic applications.
The journal has demonstrated a dynamic evolution in its focus, reflecting contemporary challenges and interests in the pharmaceutical sciences. Recent publications indicate several emerging themes that are gaining traction among researchers.
  1. Digital Health and Technology in Pharmacy:
    An increasing number of studies explore the integration of digital tools and technologies in pharmacy practice, including telepharmacy and data analytics for improving patient outcomes.
  2. Patient-Centric Research:
    Research emphasizing patient engagement, adherence to therapy, and the role of pharmacists in community settings is on the rise, highlighting the importance of patient perspectives in pharmaceutical care.
  3. Pharmacogenomics and Personalized Medicine:
    Emerging research on the genetic basis of drug response is gaining attention, with implications for tailoring therapies to individual patients based on their genetic profiles.
  4. Impact of Pandemics on Drug Use and Patient Care:
    The COVID-19 pandemic has spurred a significant increase in studies evaluating drug use patterns, vaccine safety, and the role of pharmacists in managing public health crises.
  5. Sustainable Pharmaceutical Practices:
    There is a growing trend towards research focusing on sustainability in pharmaceutical manufacturing and drug delivery systems, reflecting global concerns about environmental impact.

Declining or Waning

While Ars Pharmaceutica continues to expand its research horizons, certain themes have shown a decline in frequency or interest. This shift may reflect evolving priorities within the field or changing research landscapes.
  1. Traditional Medicinal Practices:
    Research focusing on traditional herbal medicines and their applications has seen a reduction, possibly due to an increasing emphasis on evidence-based and clinical research.
  2. Pharmaceutical Marketing and Regulations:
    Themes related to the marketing authorization of drugs and regulatory affairs have become less prominent, suggesting a shift towards more practical clinical applications and patient-centered research.
  3. Single Disease Focus Studies:
    Studies addressing specific diseases without broader implications or interdisciplinary approaches have decreased, indicating a trend towards more integrated and holistic health research.
  4. Historical Perspectives in Pharmacy:
    Papers exploring historical aspects of pharmaceutical practices and education have waned, as current research trends lean towards contemporary issues and advancements.

Similar Journals

Annales Pharmaceutiques Francaises

Advancing Pharmaceutical Knowledge Since 1945
Publisher: MASSON EDITEURISSN: 0003-4509Frequency: 6 issues/year

Annales Pharmaceutiques Francaises, an esteemed journal published by MASSON EDITEUR, serves as a pivotal platform in the field of Pharmaceutical Science and Pharmacology. Established in 1945 and continuing through 2024, this journal showcases significant contributions to the advancement of pharmaceutical sciences, bridging the gap between research, development, and practical applications. Although it currently does not offer open access, its established reputation and Q3 ranking in both Pharmaceutical Science and Pharmacology highlight its role in disseminating impactful studies. With an ISSN of 0003-4509, the journal is indexed in Scopus, boasting a respectable percentile ranking for both domains, and remains a vital resource for researchers, professionals, and students dedicated to exploring the latest advancements in the pharmaceutical field. Based in France, at 21 Street Camille Desmoulins, Issy, 92789 Moulinais Cedex 9, it aims to foster a deeper understanding of pharmacological innovations and therapeutic agents among its diverse readership.

Istanbul Journal of Pharmacy

Discovering innovations in pharmaceutical sciences.
Publisher: ISTANBUL UNIV, FAC PHARMACYISSN: Frequency: 3 issues/year

Istanbul Journal of Pharmacy, published by Istanbul University, Faculty of Pharmacy, is a pivotal platform dedicated to the advancement of pharmaceutical sciences and technology. This journal serves as a vital resource for researchers, professionals, and students alike, seeking to disseminate cutting-edge research, reviews, and innovative methodologies within the pharmaceutical discipline. With a commitment to open access, the journal aims to foster a collaborative environment that promotes information sharing and scholarly discourse. The Istanbul Journal of Pharmacy invites submissions that delve into diverse topics ranging from drug formulation to pharmacokinetics, ensuring that readers are equipped with the latest insights and discoveries in the field. This journal is positioned to enhance scientific communication within the pharmaceutical community and support the continuous evolution of pharmacy practice and education globally.

Brazilian Journal of Pharmaceutical Sciences

Unveiling the Future of Pharmaceutics Through Open Access.
Publisher: UNIV SAO PAULO, CONJUNTO QUIMICASISSN: 1984-8250Frequency: 4 issues/year

The Brazilian Journal of Pharmaceutical Sciences is a prestigious and peer-reviewed journal dedicated to disseminating significant research across the fields of Pharmacology, Toxicology, and Pharmaceutics. Published by UNIV SAO PAULO, CONJUNTO QUIMICAS, this journal has been an Open Access platform since 2009, making it accessible to a global audience, fostering collaboration and knowledge sharing among researchers and professionals. With an ISSN of 1984-8250 and an E-ISSN of 2175-9790, it holds a respectable Q3 ranking in these fields for 2023, indicating its contribution to the scientific community's understanding and advancement of pharmaceutical sciences. As it converges from 2009 to 2024, the journal continues to address emerging trends and critical topics in drug development, safety, and efficacy, positioning itself as an essential resource for students, researchers, and practitioners seeking to contribute to and stay informed about advancements in pharmacological research. With its publication address in São Paulo, Brazil, the journal serves as a key outlet for Brazilian and international scholars alike.

Pakistan Journal of Pharmaceutical Sciences

Empowering researchers with cutting-edge findings in pharmacology.
Publisher: UNIV KARACHIISSN: 1011-601XFrequency: 4 issues/year

Pakistan Journal of Pharmaceutical Sciences, published by the University of Karachi, serves as a vital platform for advancing research in the field of pharmaceutical sciences. With a strong commitment to disseminating innovative findings and critical studies since its inception in 1995, the journal focuses on a wide array of topics including pharmacology, toxicology, and pharmaceutics. With an ISSN of 1011-601X, it holds a reputable position within the academic community, reflecting its Q3 category ranking in Pharmaceutical Science as of 2023. While the journal is currently not designated as Open Access, it remains accessible through institutional subscriptions, ensuring that both emerging and established researchers can contribute to and benefit from its scholarly content. This publication not only promotes scientific dialogue but also aims to bridge the gap between academia and industry, appealing to a diverse audience of researchers, professionals, and students seeking to stay informed about the latest advancements and trends in pharmaceutical research.

Journal of Pharmacy and Bioallied Sciences

Catalyzing Change Through Open Access Research
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 0976-4879Frequency: 6 issues/year

The Journal of Pharmacy and Bioallied Sciences is a premier open access publication that has been contributing to the fields of Pharmacy, Bioengineering, and Biochemistry since its establishment in India, under the esteemed Wolters Kluwer Medknow Publications. With the ISSN 0976-4879 and E-ISSN 0975-7406, this journal provides a platform for high-quality research articles, reviews, and clinical studies aimed at advancing knowledge and practice in the pharmaceutical and allied sciences. As a reflection of its academic stature, the journal holds a respectable categorization within the third and fourth quartiles in pertinent fields according to the latest metrics, with rankings that place it among prominent emerging research in pharmacology and biochemistry. Researchers and professionals are encouraged to access a wealth of knowledge freely, as the journal has been open access since 2010. The journal not only aims to foster innovative research but also strives to bridge the gap between pharmaceutical sciences and real-world applications, making it an essential resource for students, academics, and industry experts alike.

JOURNAL OF PHARMACY PRACTICE

Connecting research and practice for a better healthcare future.
Publisher: SAGE PUBLICATIONS INCISSN: 0897-1900Frequency: 6 issues/year

JOURNAL OF PHARMACY PRACTICE, published by SAGE PUBLICATIONS INC, is a vital resource for researchers, pharmacy practitioners, and students dedicated to advancing the pharmacological and pharmaceutical sciences. Established in 1988, the journal serves as a platform for original research, reviews, and critical analyses in the fields of pharmacy and pharmacology. With an impressive impact factor and a strong presence in the Q2 category in Pharmacy and Q3 in Pharmacology (medical) as of 2023, it reflects the journal's commitment to delivering high-quality scholarly content that addresses pressing issues in pharmacy practice and medication management. The journal is indexed in Scopus, ranking #154 out of 272 in the field of Medicine and Pharmacology, positioning it within the 43rd percentile. Although it currently does not offer open access options, it remains an essential publication for those seeking to stay updated on innovations and best practices in the pharmacy sector, making it an indispensable tool for academic and professional growth.

TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH

Connecting scholars to tackle health challenges in the tropics.
Publisher: PHARMACOTHERAPY GROUPISSN: 1596-5996Frequency: 2 issues/year

Tropical Journal of Pharmaceutical Research is an esteemed open-access platform dedicated to advancing the field of pharmaceutical sciences, published by the Pharmacotherapy Group in Nigeria. With an ISSN of 1596-5996 and open access established since 2002, this journal serves as a critical resource for researchers, professionals, and students seeking to disseminate and access high-quality research in both pharmaceutical science and pharmacology. Despite its ranking in the third quartile (Q3) for Pharmaceutical Science and the fourth quartile (Q4) in Pharmacology as of 2023, the journal continues to stand out with its commitment to fostering significant dialogue and innovation in the scientific community. Anchored at the University of Benin, Faculty of Pharmacy, the journal invites contributions that explore novel pharmaceutical research, clinical applications, and drug development, playing a vital role in addressing health challenges that are particularly relevant to tropical regions. Researchers can look forward to publishing their findings in a journal that not only promotes the sharing of knowledge but also enhances the scientific discourse within a rapidly evolving field.

BIOLOGICAL & PHARMACEUTICAL BULLETIN

Unlocking New Horizons in Pharmaceutical Research
Publisher: PHARMACEUTICAL SOC JAPANISSN: 0918-6158Frequency: 12 issues/year

BIOLOGICAL & PHARMACEUTICAL BULLETIN, published by the PHARMACEUTICAL SOC JAPAN, is a prominent peer-reviewed journal that serves the fields of medicine, pharmaceutical science, and pharmacology. With an ISSN of 0918-6158 and an E-ISSN of 1347-5215, this publication has been crucial in disseminating innovative research since its inception in 1993, and it continues to contribute significantly to the body of knowledge as it converges towards 2024. Despite being classified as a non-open access journal, it maintains a respectable Q3 ranking in Medicine (miscellaneous) and Q2 in Pharmaceutical Science, highlighting its critical role in advancing scientific discourse in these areas. With Scopus rankings placing it in the 51st percentile for Pharmaceutical Science and 38th percentile for Pharmacology, BIOLOGICAL & PHARMACEUTICAL BULLETIN is an essential resource for researchers, professionals, and students looking to stay abreast of cutting-edge developments and trends in biomedicine and drug development.

Acta Pharmaceutica Sinica B

Unlocking New Horizons in Pharmacology and Toxicology
Publisher: INST MATERIA MEDICA, CHINESE ACAD MEDICAL SCIENCESISSN: 2211-3835Frequency: 6 issues/year

Acta Pharmaceutica Sinica B is a prestigious open access journal that has been setting the standard in the field of pharmacology, toxicology, and pharmaceutics since its establishment in 2011. Published by the Institute of Materia Medica, Chinese Academy of Medical Sciences, the journal serves as a vital platform for researchers, professionals, and students seeking to disseminate innovative findings in drug development, pharmaceutical sciences, and therapeutic applications. With an impressive impact factor reflecting its high academic quality, Acta Pharmaceutica Sinica B has achieved Q1 status in the category of Pharmacology, Toxicology and Pharmaceutics as of 2023, ranking #1 out of 80 journals in General Pharmacology. This journal not only focuses on the latest advancements in drug research and formulation but also emphasizes interdisciplinary approaches, fostering collaborations that span various scientific domains. The accessible nature of the journal, combined with its rigorous peer-review process, ensures that crucial insights and breakthroughs reach a global audience swiftly and effectively. For those looking to stay at the forefront of pharmaceutical research, Acta Pharmaceutica Sinica B is an indispensable resource.

Journal of Young Pharmacists

Advancing Research for the Next Generation of Pharmacists
Publisher: INPHARM ASSOC, PHCOG NETISSN: 0975-1483Frequency: 4 issues/year

Journal of Young Pharmacists is a distinguished peer-reviewed journal published by INPHARM ASSOCIATION in collaboration with PHCOG NET. With an ISSN of 0975-1483 and an E-ISSN of 0975-1505, this journal serves as a vital platform for disseminating pioneering research in the field of pharmacology and toxicology. Although coverage in Scopus was discontinued in 2018, the journal continues to be important in educating future pharmacists and advancing the discipline, evident from its ranking in the 29th percentile among general pharmacology journals. The Journal of Young Pharmacists seeks to bridge the gap between theoretical knowledge and practical application, encouraging young researchers, professionals, and students to contribute their insights and findings. The journal emphasizes innovative approaches and contemporary issues relevant to the pharmaceutical sciences, making it an invaluable resource for anyone involved in this dynamic field.